Robert Spiegel
Director/Board Member at GERON CORPORATION
Net worth: 596 249 $ as of 2024-03-30
Profile
Robert Jay Spiegel is the founder of Spiegel Consultants, LLC, which was founded in 2010.
He is currently the Vice Chairman at Cyclacel Pharmaceuticals, Inc., an Independent Director at Geron Corp., Athenex, Inc., RenovoRx, Inc., Sun Pharma Advanced Research Co. Ltd., and Ayala Pharmaceuticals, Inc. He is also an Advisor at Warburg Pincus & Company US LLC, an Associate Professor at Weill Cornell Medical College, and a Venture Advisor at Israel Biotech Fund.
Dr. Spiegel has held former positions as Chairman at NexImmune, Inc., Independent Director at Capstone Therapeutics Corp., Director at Avior Computing Corp., Independent Director at Edge Therapeutics, Inc., Director at Talon Therapeutics, Inc., Director at Advaxis, Inc., Independent Director at Sucampo Pharmaceuticals LLC, Director at Weifa ASA, Director at The Cancer Institute of New Jersey, Director at CancerCare of New Jersey, Director at Vidac Pharma Ltd., Director-Developmental Therapeutics at New York University Medical Center, Director at PDS Biotechnology Corp., and Independent Director at Old Ayala, Inc. He was also the Chief Medical Officer & Senior Vice President at Schering-Plough Research Institute and Senior Vice President at Worldwide Clinical Research, Inc. Dr. Spiegel holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Yale University (conferred in 1971).
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
GERON CORPORATION
0.03% | 2024-02-29 | 164,040 ( 0.03% ) | 541 332 $ | 2024-03-30 |
RENOVORX, INC.
0.38% | 2024-03-06 | 40,983 ( 0.38% ) | 54 917 $ | 2024-03-30 |
Robert Spiegel active positions
Companies | Position | Start |
---|---|---|
GERON CORPORATION | Director/Board Member | 2010-05-20 |
CYCLACEL PHARMACEUTICALS, INC. | Director/Board Member | 2018-09-11 |
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED | Director/Board Member | 2020-05-31 |
ATHENEXPAR | Director/Board Member | 2020-08-03 |
RENOVORX, INC. | Director/Board Member | 2023-04-24 |
AYALA PHARMACEUTICALS, INC. | Director/Board Member | 2017-11-30 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | 2014-12-31 |
Warburg Pincus & Company US LLC
Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Consultant / Advisor | 2009-12-31 |
Spiegel Consultants, LLC | Founder | 2009-12-31 |
░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Former positions of Robert Spiegel
Companies | Position | End |
---|---|---|
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Robert Spiegel
University of Pennsylvania | Doctorate Degree |
Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 9 |
---|---|
CAPSTONE HOLDING CORP. | Health Technology |
GERON CORPORATION | Health Technology |
PTC THERAPEUTICS, INC. | Health Technology |
NEXIMMUNE, INC. | Health Technology |
RENOVORX, INC. | Health Technology |
CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED | Health Technology |
PDS BIOTECHNOLOGY CORPORATION | Health Technology |
AYALA PHARMACEUTICALS, INC. | Commercial Services |
Private companies | 18 |
---|---|
Athenex, Inc.
Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Avior Computing Corp.
Avior Computing Corp. Packaged SoftwareTechnology Services Avior Computing Corp. provides enterprise governance, risk, and compliance solutions. It offers ClearView, an automated regulatory compliance mapping solution; and BenchMark, a compliance process management software solution. The company was founded by Stephen A. McCalmont and Michael B. Courtemanche in 2003 and is headquartered in Nashua, NH. | Technology Services |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
Warburg Pincus & Company US LLC
Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Finance |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Weifa ASA
Weifa ASA Pharmaceuticals: MajorHealth Technology Weifa ASA engages in the development, production and sales of medicines and other health products. Its products include medicines for pain relief, cough and cold, nutraceuticals, and dermatology. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |
The Cancer Institute of New Jersey
The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Health Services |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
Worldwide Clinical Research, Inc.
Worldwide Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd., Worldwide Clinical Research, Inc. provides management consulting services to the clinical research industry. The private company is based in Overland Park, KS. The company was founded by Barbara J. Geiger. Worldwide Clinical Research was acquired by Clinipace, Inc., part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. from April 28, 2021 on November 09, 2009. | Commercial Services |
Oncology Clinical Research & Development | |
CancerCare of New Jersey | |
Vidac Pharma Ltd.
Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Spiegel Consultants, LLC | |
New York University Medical Center
New York University Medical Center Other Consumer ServicesConsumer Services Part of New York University, New York University Medical Center is a healthcare provider that offers personalized treatment for reproductive and sexual health conditions in men and women. The private company is based in New York and provides emergency and urgent care at various locations, as well as Virtual Urgent Care. NYU Langone's Community Health Needs Assessment and Service Plan aims to support behavior change and disease prevention at the neighborhood level. The American company was founded by J. Ira Harris. | Consumer Services |
Old Ayala, Inc.
Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Robert Spiegel